TAG: obesity treatment

After a year in Brazil, Mounjaro revolutionizes the approach to obesity for metabolic health

Regulatory agency authorizes increase in the weekly dose of the drug Poviztra to 7.2 mg against obesity

Experts detail who can and who should avoid weight loss pens like Ozempic Wegovy Mounjaro

Ozempic patent expiry promises major shift in public health access and cost savings by 2025

Endocrinologist details critical link between weight loss pens, pancreatitis risk, and secure usage

US obesity treatment transformed with affordable Novo Nordisk oral pill

Notícia sobre New era for weight-loss drugs after US approves pill version of Wegovy